These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 25313924)

  • 1. Continuous subcutaneous use of levetiracetam: a retrospective review of tolerability and clinical effects.
    Rémi C; Lorenzl S; Vyhnalek B; Rastorfer K; Feddersen B
    J Pain Palliat Care Pharmacother; 2014 Dec; 28(4):371-7. PubMed ID: 25313924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety and tolerability of different intravenous administrations of levetiracetam, bolus versus infusion, in intensive care unit patients.
    Burakgazi E; Bashir S; Doss V; Pellock J
    Clin EEG Neurosci; 2014 Apr; 45(2):89-91. PubMed ID: 24357676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy.
    Li S; Cao J; Xiao N; Cai F
    J Child Neurol; 2010 May; 25(5):609-13. PubMed ID: 19779208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levetiracetam in pediatrics.
    Vigevano F
    J Child Neurol; 2005 Feb; 20(2):87-93. PubMed ID: 15794171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levetiracetam in children, adolescents and young adults with intractable epilepsy: efficacy, tolerability and effect on electroencephalogram--a pilot study.
    Goldberg-Stern H; Feldman L; Eidlitz-Markus T; Kramer U; Perez S; Pollak L; Phatal-Valevski A
    Eur J Paediatr Neurol; 2013 May; 17(3):248-53. PubMed ID: 23159714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of levetiracetam in refractory status epilepticus.
    Patel NC; Landan IR; Levin J; Szaflarski J; Wilner AN
    Seizure; 2006 Apr; 15(3):137-41. PubMed ID: 16426869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
    Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
    Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous levetiracetam in children with seizures: a prospective safety study.
    Ng YT; Hastriter EV; Cardenas JF; Khoury EM; Chapman KE
    J Child Neurol; 2010 May; 25(5):551-5. PubMed ID: 20413804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experience with levetiracetam in childhood epilepsy].
    Neuwirth M; Saracz J; Hegyi M; Paraicz E; Kollár K; Móser J; Rosdy B; Herczegfalvi A; Fogarasi A
    Ideggyogy Sz; 2006 May; 59(5-6):179-82. PubMed ID: 16786712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of levetiracetam: a review of three pivotal clinical trials.
    Privitera M
    Epilepsia; 2001; 42 Suppl 4():31-5. PubMed ID: 11564123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuation rates of levetiracetam in children from the EULEVp cohort study.
    Dureau-Pournin C; Pédespan JM; Droz-Perroteau C; Lavernhe G; Mann M; Pollet C; Robinson P; Jové J; Moore N; Fourrier-Réglat A;
    Eur J Paediatr Neurol; 2014 Jan; 18(1):19-24. PubMed ID: 24035600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long-term efficacy and safety of levetiracetam in a tertiary epilepsy centre.
    Kang BS; Moon HJ; Kim YS; Lee ST; Jung KH; Chu K; Lee SK
    Epileptic Disord; 2013 Sep; 15(3):302-10. PubMed ID: 23981665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy.
    Betts T; Waegemans T; Crawford P
    Seizure; 2000 Mar; 9(2):80-7. PubMed ID: 10845730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptability and tolerability of levetiracetam oral solution for the treatment of partial-onset seizures: the SOLUCIÓN study.
    Matías-Guíu J; Molins A; Mauri JA; Villar E
    Methods Find Exp Clin Pharmacol; 2010 Sep; 32(7):507-16. PubMed ID: 21069102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levetiracetam: treatment in epilepsy.
    Ben-Menachem E
    Expert Opin Pharmacother; 2003 Nov; 4(11):2079-88. PubMed ID: 14596661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with intravenous levetiracetam in status epilepticus: a retrospective case series.
    Gámez-Leyva G; Aristín JL; Fernández E; Pascual J
    CNS Drugs; 2009 Nov; 23(11):983-7. PubMed ID: 19845418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remember Keppra: seizure control with subcutaneous levetiracetam infusion.
    Murray-Brown FL; Stewart A
    BMJ Support Palliat Care; 2016 Mar; 6(1):12-3. PubMed ID: 26811092
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapid infusion of a loading dose of intravenous levetiracetam with minimal dilution: a safety study.
    Wheless JW; Clarke D; Hovinga CA; Ellis M; Durmeier M; McGregor A; Perkins F
    J Child Neurol; 2009 Aug; 24(8):946-51. PubMed ID: 19264738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.